Analyst Research Report Snapshot

Title:

CONSORT MEDICAL - CONSORTIUM INVESTMENT

Price:

$10.00

Provider:

Edison Investment Research

Date:

20 Jul 2011

Pages:

2

Type:

AcrobatPDF

Companies referenced:

CSRT.L

Available for Immediate Download
Summary:

Consort Medical, in conjunction with a consortium, is making its second investment in private UK healthcare technology company Atlas Genetics. The consortium’s £16.9m investment follows Consort’s previous £1.5m investment (for a 19.5% stake in Atlas). It will be used to develop the core Velox ultra rapid point-of-care molecular diagnostic platform and broaden the range of tests available. Consort’s Bespak division is undertaking the design-to-manufacture scale-up of the Velox test cartridge and has long-term manufacturing rights. EU launch is expected by the end of 2012.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.